This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Transcription factor MafF.
Interacts with the upstream promoter region of the oxytocin receptor gene. May be a transcriptional enhancer in the up-regulation of the oxytocin receptor gene at parturition.
Mouse | |
---|---|
Gene Name: | Maff |
Uniprot: | O54791 |
Entrez: | 17133 |
Belongs to: |
---|
bZIP family |
hMafF; MafF; transcription factor MafF; U-Maf; v-maf avian musculoaponeurotic fibrosarcoma oncogene family protein F; v-maf musculoaponeurotic fibrosarcoma (avian) oncogene family, protein F; v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian); V-maf musculoaponeurotic fibrosarcoma oncogene homolog F
Mass (kDA):
16.955 kDA
Mouse | |
---|---|
Location: | 15 E1|15 37.7 cM |
Sequence: | 15; |
Highly expressed in the lung, lower expression in the brain, thymus, liver, spleen, intestine, kidney, heart, muscle, and ovary. Not significantly expressed in hematopoietic cells.
If you are a researcher, the MAFFMarker may be familiar to you. Did you know you could also use it for research? This article provides information regarding MAFF markers and their costs. This article provides information about MAFF markers and their uses for research. It will provide you with some useful tips to help you decide if MAFF markers are right for you.
In this review we highlight the benefits of Boster's Anti-MAFF Marker Monoclonally-Activated Monoclonal Antibody. It has been tested and proven effective against several cancer-related proteins. Its high affinity has been validated through immunohistochemistry, Western Blotting, and ELISA. It is suitable to study a variety if cancers, including Leukemia.
MAFF is an abundant protein found in the bloodstreams of cancer patients. It is useful in the diagnosis and monitoring of cancer patients. It has potential uses in cancer screening and diagnosis, as well as prognosis and treatment. Its clinical utility is limited due to the low incidence of most cancers. Routine screening for prostate and ovarian carcinoma is currently limited to the PSA and CA125. Their low sensitivity, low specificity and limited utility in early cancer diagnosis limit their use.
Numerous tumor markers are available and have been tested. Their value will depend on the nature and effectiveness of the therapies. Some have been useful in determining prognosis and screening for occult or advanced cancers. Below are the clinical applications for the MAFF marker. We discuss their potential in cancer diagnosis and their limitations. There are five main types of cancer markers:
The MAFF Marker price varies depending on what type of marker you use. Some markers have a low MAF and others have a higher MAF. Some statutory requirements must be met while others relate to MAFF’s objectives for animal welfare and public health. MAFF funds some research projects that address animal welfare and disease. Continue reading for more information. You can also find out which types research are currently funded.
MAFF aims for a compensatory increase in research spending by the food and agricultural industries. Increasing investment in science will improve the industrial competitiveness and productivity of the agricultural industry. They can compete for market share with other countries by having this money. It is a key factor in their competitiveness and improves the welfare of consumers. And it doesn't cost the government much, either.
PMID: 10409670 by Onodera K., et al. Characterization of the murine mafF gene.